Author

Simon M. Agwale

Observed names: Agwale, Simon M., Simon Agwale, Simon M Agwale, Simon Magaji Agwale, SimonM Agwale

Observed institutions: University of Maryland, Baltimore, Centers for Disease Control and Prevention, National Institutes of Health, University of Jos, Instituto de Salud Carlos III, Nasarawa State University, National Institute for Pharmaceutical Research and Development, National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, National Center for Infectious Diseases, Vaccine Research Center, Instituto Oswaldo Cruz

OpenAlex ID: A5108727942

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

2018 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet Infectious Diseases · 439

PDF

Recent advances with recombinant bacterial vaccine vectors

2000 · Mohamed T Shata, Liljana Stevceva, et al. · Molecular Medicine Today · 111

Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

2020 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet HIV · 104

Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria

2009 · Moses P. Adoga, Edmund B. Banwat, et al. · The Journal of Infection in Developing Countries · 94

PDF

H3Africa: a tipping point for a revolution in bioinformatics, genomics and health research in Africa

2014 · Moses P Adoga, Segun A Fatumo, et al. · Source Code for Biology and Medicine · 82

PDF

Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes

2004 · Simon M. Agwale, Lorine Tanimoto, et al. · Journal of Clinical Virology · 62

Armed conflict, a neglected determinant of childhood vaccination: some children are left behind

2019 · Ngo Valery Ngo, Ngambouk Vitalis Pemunta, et al. · Human Vaccines & Immunotherapeutics · 57

Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests

2010 · Moses P. Adoga, Silas D. Gyar, et al. · The Journal of Infection in Developing Countries · 52

PDF

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership

2009 · Mecky I Matee, Christine Manyando, et al. · BMC Public Health · 51

PDF

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1

2004 · Danuta Pieniazek, Mark Rayfield, et al. · AIDS · 46

Genotypic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 in Antiretroviral Drug-Naive Nigerian Patients

2006 · Simon M. Agwale, Clement Zeh, et al. · AIDS Research and Human Retroviruses · 35

Prevalence of Hepatitis B e Antigen in Chronic HBV Carriers in North-central Nigeria

2013 · Joseph C Forbi, Odunayo H Iperepolu, et al. · Journal of Health Population and Nutrition · 32

PDF

Serologic survey of specific rubella virus IgM in the sera of pregnant women in Makurdi, Benue State, Nigeria.

2009 · Grace Pennap, Ginikanwa Amauche, et al. · PubMed · 30

PDF

Application of dried blood spot in the sero-diagnosis of hepatitis B infection (HBV) in an HBV hyper-endemic nation

2010 · JosephC Forbi, JoyO Obagu, et al. · Annals of African Medicine · 23

HIV point-of-care diagnostics: meeting the special needs of sub-Saharan Africa

2014 · Godwin Abazho Aleku, Moses P Adoga, et al. · The Journal of Infection in Developing Countries · 22

PDF

Estimating the time period between infection and diagnosis based on CD4+ counts at first diagnosis among HIV-1 antiretroviral naïve patients in Nigeria

2010 · Joseph C Forbi, Thanda D Forbi, et al. · The Journal of Infection in Developing Countries · 18

PDF

Nigerian HIV Type 2 Subtype A and B from Heterotypic HIV Type 1 and HIV Type 2 or Monotypic HIV Type 2 Infections

2005 · Clement Zeh, Danuta Pieniazek, et al. · AIDS Research and Human Retroviruses · 18

Genetic Variability of HIV-1 Protease from Nigeria and Correlation with Protease Inhibitors Drug Resistance

2001 · Ana Carolina P. Vicente, Simon M. Agwale, et al. · Virus Genes · 15

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

2002 · David M Hone, Anthony L DeVico, et al. · PubMed · 14

Estimates of human immunodeficiency virus incidence among female sex workers in north central Nigeria: implications for HIV clinical trials

2011 · Joseph C. Forbi, Peter E. Entonu, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 11

European and developing countries clinical trials partnership (EDCTP)

2009 · Simon M. Agwale, Walter Jaoko, et al. · 10

Antiretroviral-Drug Resistant Mutations and Genetic Diversity in HIV-1 Infected Individuals in Nigeria

2014 · Olubunmi Ruth Negedu-Momoh, Olayeni Stephen Olonitola, et al. · World Journal of AIDS · 9

PDF

Molecular Characterization of Hepatitis A Virus Isolates from Nigeria

2012 · Joseph C. Forbi, Mathew D. Esona, et al. · Intervirology · 9

Genetic analysis of hepatitis A virus variants circulating among children presenting with acute diarrhea in Cameroon

2012 · Joseph C. Forbi, Simon M. Agwale, et al. · Journal of Medical Virology · 9

Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population

2010 · Moses P. Adoga, Grace Pennap, et al. · The Journal of Infection in Developing Countries · 9

PDF

Works count: 39

Citation count: 1,396

H-index: 17

I10-index: 21